Nervous system of mite or louse

The "nervous system of mites/lice" is not a single molecular target but refers broadly to the entire neural architecture found in these arthropods. Both mites and lice possess highly condensed central nervous systems typical for small arthropods. In mites, this consists primarily of the synganglion—a fused mass containing both supraesophageal and subesophageal regions that integrates sensory input and coordinates movement[1][3][5]. The general structure includes a dorsal brain connected by circumesophageal connectives to ventral nerve cords composed of ganglia[2][4][8][9]. These ganglia control various body segments autonomously. Sensory functions are mediated by specialized cuticular structures such as setae for mechanoreception and chemoreception[5][8][9]. The neuromuscular organization differs from vertebrates; multiple neuron types innervate each muscle cell rather than forming motor units as seen in mammals[9]. In terms of therapeutic intervention, drugs like permethrin or ivermectin act on components within this neural network—most commonly voltage-gated sodium channels or neurotransmitter receptors—but there is no single canonical protein or receptor universally referred to as "the nervous system" that serves as an established drug target. Therefore, listing "Nervous system of mites/lice" as a therapeutic target is incorrect; it should be replaced with specific molecular targets such as "Voltage-gated sodium channel alpha subunit (mite)" if known. This entry is too broad for structured pharmacological databases because it does not refer to an individual molecule, protein family, or defined receptor/enzyme/transporter. It encompasses an entire organ/system rather than a discrete druggable entity.

Other names

Mite nervous systemLouse nervous systemArthropod nervous system (in context)

Disruption of ion channels (e.g., sodium channel blockers like permethrin); Interference with neurotransmission (e.g., GABA receptor antagonists in some acaricides)